The big idea: the coxib crisis iron, aspirin and heart disease risk revisited.
作者信息
Sullivan Jerome L
机构信息
Burnett College of Biomedical Sciences, University of Central Florida, Orlando, Florida, USA.
出版信息
J R Soc Med. 2007 Jul;100(7):346-9. doi: 10.1177/014107680710000721.
Abstract
摘要
相似文献
1
The big idea: the coxib crisis iron, aspirin and heart disease risk revisited.核心观点：昔布类药物危机——铁、阿司匹林与心脏病风险再探讨
J R Soc Med. 2007 Jul;100(7):346-9. doi: 10.1177/014107680710000721.
2
Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs.非甾体抗炎药的心血管效应
Curr Cardiol Rep. 2016 Mar;18(3):25. doi: 10.1007/s11886-016-0702-4.
3
Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin.关于使用非甾体抗炎药（包括环氧化酶-2酶抑制剂和阿司匹林）的共识发展会议。
Clin Gastroenterol Hepatol. 2006 Sep;4(9):1082-9. doi: 10.1016/j.cgh.2006.04.010. Epub 2006 Jul 31.
4
[Application of aspirin and other non-steroid anti-inflammatory drugs in cardiology. Cardiologist's expert opinion].[阿司匹林及其他非甾体类抗炎药在心脏病学中的应用。心脏病专家的专家意见]
Eksp Klin Gastroenterol. 2006(2):10-2.
5
Cardiovascular effects of low-dose aspirin, traditional non-steroidal anti-inflammatory drugs and coxibs.
Bull Mem Acad R Med Belg. 2010;165(1-2):115-23; discussion 124.
6
7
Risk of low-dose aspirin: emphasis on outliers undermines the credibility of the conclusions.
Aliment Pharmacol Ther. 2007 Feb 1;25(3):345-6; author reply 346-7. doi: 10.1111/j.1365-2036.2006.03192.x. Epub 2007 Jan 8.
8
Effect of dosage on coxib- or nonsteroidal antiinflammatory drug-associated cardiovascular risk? Comment on the article by Solomon et al.剂量对环氧化酶-2选择性抑制剂或非甾体抗炎药相关心血管风险的影响？对所罗门等人文章的评论
Arthritis Rheum. 2007 Jan;56(1):384; author reply 384. doi: 10.1002/art.22283.
9
What price pain relief?止痛的代价是什么？
Circulation. 2006 Jun 27;113(25):2868-70. doi: 10.1161/CIRCULATIONAHA.106.634386. Epub 2006 Jun 19.
10
Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers.美国初级保健提供者对阿司匹林、非甾体抗炎药和环氧化酶-2选择性非甾体抗炎药的认知与实践的变化
Aliment Pharmacol Ther. 2008 Nov 15;28(10):1249-58. doi: 10.1111/j.1365-2036.2008.03836.x. Epub 2008 Aug 22.
引用本文的文献
1
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.铁的不良表现：不适当的铁螯合是血管及其他进行性炎症和退行性疾病病因的主要促成因素。
BMC Med Genomics. 2009 Jan 8;2:2. doi: 10.1186/1755-8794-2-2.
本文引用的文献
1
Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association.非甾体抗炎药的使用：临床医生最新指南：美国心脏协会的科学声明
Circulation. 2007 Mar 27;115(12):1634-42. doi: 10.1161/CIRCULATIONAHA.106.181424. Epub 2007 Feb 26.
2
Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial.外周动脉疾病患者使用阿司匹林预防严重血管事件：随机双盲试验
J Intern Med. 2007 Mar;261(3):276-84. doi: 10.1111/j.1365-2796.2006.01763.x.
3
Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial.外周动脉疾病患者铁储备降低与心血管结局：一项随机对照试验。
JAMA. 2007 Feb 14;297(6):603-10. doi: 10.1001/jama.297.6.603.
4
Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques.人体铁储存与低分子量铁及人类动脉粥样硬化斑块氧化损伤的关联
Free Radic Biol Med. 2007 Feb 15;42(4):492-8. doi: 10.1016/j.freeradbiomed.2006.11.014. Epub 2006 Nov 17.
5
Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis.多国依托考昔与双氯芬酸关节炎长期（MEDAL）研究项目的临床试验设计及患者人口统计学特征：骨关节炎和类风湿关节炎患者中依托考昔与双氯芬酸的心血管结局
Am Heart J. 2006 Aug;152(2):237-45. doi: 10.1016/j.ahj.2006.05.024.
6
NEJM "failed its readers" by delay in publishing its concerns about VIGOR trial.《新英格兰医学杂志》因延迟发表其对VIGOR试验的担忧而“辜负了读者”。
BMJ. 2006 Jul 15;333(7559):116. doi: 10.1136/bmj.333.7559.116-f.
7
Cyclooxygenase inhibition and cardiovascular risk.环氧化酶抑制与心血管风险。
Circulation. 2005 Aug 2;112(5):759-70. doi: 10.1161/CIRCULATIONAHA.105.568451.
8
Stored iron and vascular reactivity.储存铁与血管反应性。
Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1532-5. doi: 10.1161/01.ATV.0000174124.20147.22.
9
Arthritis medicines and cardiovascular events--"house of coxibs".关节炎药物与心血管事件——“昔布类药物家族”
JAMA. 2005 Jan 19;293(3):366-8. doi: 10.1001/jama.293.3.366. Epub 2004 Dec 28.
10
Is stored iron safe?储存铁是否安全？
J Lab Clin Med. 2004 Dec;144(6):280-4. doi: 10.1016/j.lab.2004.10.006.
Zotero 插件